Proceeds to Support Key Efficacy Studies for ABI-2280 including Phase 2 Trial in High-Grade Cervical Intraepithelial Neoplasia (CIN 2,3) and Exploratory Study as Treatment for High-Risk HPV Infections SOUTH SAN FRANCISCO, April 27, 2023 /PRNewswire/ -- Antiva Biosciences, a...
News Ticker
- [ June 10, 2023 ] Senior Manager, Field Market Access Operations Analytics (REMOTE) – Jazz Pharmaceuticals – Palo Alto, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Senior Research Associate – Bruker – San Jose, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Sr. Associate Scientist, Upstream Development for Protein Development and Manufacturing – Vaxcyte – San Carlos, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Research Associate/Senior Research Associate – Vector Engineering – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ June 10, 2023 ] Sr. Scientist, Upstream Development for Protein Development and Manufacturing – Vaxcyte – San Carlos, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
